PK Mishra, Prime Minister's Principal Secretary "Should the...
Category:
Eco/Invest/Demography
Latest
Sensex surges to record high, investors gain Rs 6.24 trillion
"Markets were on a roll on the back of across-the-board buying as...
Banks must use UPI to create more digital opportunities to empower millions: FM Sitharaman
Nirmala Sitharaman, Union Finance Minister As banks benefit from...
IRDAI seeks insurers’ compliance on issuance of ESOPs
The prior approval of the IRDA has to be sought before such exercise.where exercise of ESOP by one or more key employees of the comoany whether singly or jointly is beyond the threshold limit specified
New Covid-19 cases in India have peaked, shows Cambridge tracker
Health services remain overwhelmed and several hospitals face shortage in oxygen supplies. The nation has reported more than 300,000 new infections for more than 20 straight days and the official tally of daily deaths has topped 4,000. The numbers are probably vastly undercounted, experts say.
The real pandemic risk from India is tracking new variants of Covid-19
India, too, needs to do its part. Even as it struggles to provide hospital beds, oxygen and antivirals to its gasping citizens, New Delhi must step up genome surveillance to figure out–for itself and the rest of the world–what exactly is going on. Plans being laid for reopening and economic recovery everywhere could depend on it.
China’s population growth slows; nation becomes older and urbanised
The share of the working-age population — those between ages of 15 and 59 — slumped to 63.4% in 2020 from more than 70% a decade ago, according to the census. Residents aged 60 and above accounted for 18.7% of the population in 2020, up from 13.3% in 2010.
Eli Lilly signs deals to boost supply of COVID-19 treatment in India
The three Indian drugmakers – Cipla Ltd , Lupin Ltd and Sun Pharma – will collaborate with U.S.-based Lilly to help make and sell baricitinib in India.The agreements will bolster India’s arsenal of drugs to battle its catastrophic second wave of the pandemic, which has led to an acute shortage of coronavirus medicines including remdesivir and tocilizumab.
Total vehicle registrations in India slips 30 pc to 1,52,71,519 units in 2020-21: FADA
”Recovery hence looks to take a longer time when compared to recovery which came after the first wave. The only ray of hope lies on the on time arrival monsoon which is likely to enter India through the southern coast around June 1,” it said.
PILs to safeguard children orphaned due to COVID: HC seeks stand of Centre, Delhi govt
A bench of Chief Justice D N Patel and Justice Jasmeet Singh issued notices to the Union ministries of home affairs, women and child development and health, the Aam Aadmi Party (AAP) government in Delhi and the city police, seeking their stand on one of the pleas moved by a lawyer, which has also asked for financial assistance for the families of the patients who died due to the alleged denial of healthcare such as hospital admissions, oxygen and medications.
Investors brace for market fallout as most of India’s states lock down
“Markets will correct if the government announces a nationwide lockdown,” said Naveen Kulkarni, chief investment officer at Axis Securities Ltd. “However, the critical factor will be the duration. The longer any lockdown is, the greater will be the correction.”
Insurance, MF players cut equity investments in Q4; LIC booked profits
Holdings by insurance companies declined to a 5-year low of 4.80 per cent as on March 31, down from 5 per cent at the end of December 31, 2020. In value terms, it went up by 3.09 per cent from the previous quarter to an all-time high of Rs 9.48 lakh crore as on March 31, 2021.
LIC accounts for over three-fourths of the overall value of the stakes held by insurance companies in equities, it added.
Mutual funds’ holding reduced to 7.23 per cent as on March 31, 2021 down from 7.42 per cent as on December 31, 2020, and Haldea said that this is the fourth straight quarter where the MFs have sold their holdings after 24 continuous quarters of an increase.
No judicial interference needed in Covid-19 vaccine policy: Centre tells SC
The affidavit added that the new ‘Liberalized Pricing and Accelerated National Covid-19 Vaccination Strategy would further ramp up the pace of COVID-19 vaccination.”